These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

618 related items for PubMed ID: 25385054

  • 1. Reversed-phase liquid chromatography with electrospray mass detection and 1H and 13C NMR characterization of new process-related impurities, including forced degradants of efavirenz: related substances correlated to the synthetic pathway.
    Gadapayale K, Kakde R, Sarma VU.
    J Sep Sci; 2015 Jan; 38(2):218-30. PubMed ID: 25385054
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D, Basniwal PK.
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A validated stability-indicating LC method for acetazolamide in the presence of degradation products and its process-related impurities.
    Srinivasu P, Subbarao DV, Vegesna RV, Sudhakar Babu K.
    J Pharm Biomed Anal; 2010 May 01; 52(1):142-8. PubMed ID: 20053517
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Development of stability-indicating UHPLC method for the quantitative determination of silodosin and its related substances.
    Shaik JV, Saladi S, Sait SS.
    J Chromatogr Sci; 2014 Aug 01; 52(7):646-53. PubMed ID: 23845884
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
    Luo Z, Deng Z, Liu Y, Wang G, Yang W, Hou C, Tang M, Yang R, Zhou H.
    Talanta; 2015 Jul 01; 139():67-74. PubMed ID: 25882410
    [Abstract] [Full Text] [Related]

  • 11. Simultaneous quantification of a non-nucleoside reverse transcriptase inhibitor efavirenz, a nucleoside reverse transcriptase inhibitor emtricitabine and a nucleotide reverse transcriptase inhibitor tenofovir in plasma by liquid chromatography positive ion electrospray tandem mass spectrometry.
    Nirogi R, Bhyrapuneni G, Kandikere V, Mudigonda K, Komarneni P, Aleti R, Mukkanti K.
    Biomed Chromatogr; 2009 Apr 01; 23(4):371-81. PubMed ID: 18937306
    [Abstract] [Full Text] [Related]

  • 12. A novel reverse phase stability indicating RP-UPLC method for the quantitative determination of fifteen related substances in Ranolazine drug substance and drug product.
    Malati V, Reddy AR, Mukkanti K, Suryanarayana MV.
    Talanta; 2012 Aug 15; 97():563-73. PubMed ID: 22841123
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Development and validation of reversed-phase HPLC gradient method for the estimation of efavirenz in plasma.
    Gupta S, Kesarla R, Chotai N, Omri A.
    PLoS One; 2017 Aug 15; 12(5):e0174777. PubMed ID: 28505168
    [Abstract] [Full Text] [Related]

  • 15. Development of a validated RP-LC/ESI-MS-MS method for separation, identification and determination of related substances of tamsulosin in bulk drugs and formulations.
    Nageswara Rao R, Kumar Talluri MV, Narasa Raju A, Shinde DD, Ramanjaneyulu GS.
    J Pharm Biomed Anal; 2008 Jan 07; 46(1):94-103. PubMed ID: 17951020
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Development and validation of a stability-indicating RP-HPL C-CAD method for gabapentin and its related impurities in presence of degradation products.
    Ragham PK, Chandrasekhar KB.
    J Pharm Biomed Anal; 2016 Jun 05; 125():122-9. PubMed ID: 27018505
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.